Aether in Ukraine: why a prosthetic hand needed a route through clinics and reimbursement

In 2024, MSSG began helping Aether Biomedical develop a route into Ukraine for its Zeus bionic hand. This account draws on the publisher’s own advisory case study. It is not an independent clinical review or a report of a new product launch.

The assignment involved more than identifying demand. The team had to understand fitting, clinical partners, certification, reimbursement, maintenance and local operations. A person’s need for a prosthesis does not by itself establish who can supply it or how it will be paid for.

MSSG’s case describes initial meetings and institutional interest that did not produce a reliable sales route. The team then revised the approach rather than treating introductions and letters of intent as completed market entry.

Several routes instead of one decision

The revised approach combined work with non-profit prosthetic centres, a public hospital, commercial clinics, the state reimbursement pathway and a local Ukrainian presence. These elements addressed different parts of the service rather than relying on one central institutional decision.

Clinical partners and prosthetists were essential to fitting and follow-up. Aether supplied the product and its own team; Ukrainian institutions, clinicians and patients were central to implementation. MSSG’s role concerned coordination, local research, relationships and the market-entry process.